Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 1.83
(4.87%)
AUD 1.83
(4.87%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -42.32 Million AUD | -72.03% |
| 2023 | -24.6 Million AUD | -3.57% |
| 2022 | -23.75 Million AUD | -132.4% |
| 2021 | -10.22 Million AUD | -46.99% |
| 2020 | -6.95 Million AUD | -88.74% |
| 2019 | -3.68 Million AUD | -114.32% |
| 2018 | -1.71 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -8.6 Million AUD | 35.62% |
| 2024 Q3 | -12.56 Million AUD | 26.98% |
| 2024 FY | -42.32 Million AUD | -72.03% |
| 2024 Q2 | -17.2 Million AUD | -100.0% |
| 2024 Q4 | -12.56 Million AUD | 0.0% |
| 2023 Q4 | -13.35 Million AUD | -100.0% |
| 2023 FY | -24.6 Million AUD | -3.57% |
| 2023 Q3 | -6.67 Million AUD | 40.58% |
| 2023 Q2 | -11.24 Million AUD | -100.0% |
| 2023 Q1 | -5.62 Million AUD | 44.02% |
| 2022 Q1 | -6.85 Million AUD | -27.77% |
| 2022 FY | -23.75 Million AUD | -132.4% |
| 2022 Q4 | -10.04 Million AUD | -100.0% |
| 2022 Q3 | -5.02 Million AUD | 63.38% |
| 2022 Q2 | -13.71 Million AUD | -100.0% |
| 2021 FY | -10.22 Million AUD | -46.99% |
| 2021 Q1 | -2.42 Million AUD | 33.62% |
| 2021 Q4 | -5.36 Million AUD | -100.0% |
| 2021 Q2 | -4.85 Million AUD | -99.98% |
| 2021 Q3 | -2.68 Million AUD | 44.74% |
| 2020 Q1 | -1.64 Million AUD | 0.0% |
| 2020 Q2 | -3.29 Million AUD | -99.98% |
| 2020 Q4 | -3.65 Million AUD | -100.0% |
| 2020 Q3 | -1.82 Million AUD | 44.52% |
| 2020 FY | -6.95 Million AUD | -88.74% |
| 2019 FY | -3.68 Million AUD | -114.32% |
| 2018 FY | -1.71 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | -686.514% |
| Acrux Limited | -5.8 Million AUD | -629.732% |
| Race Oncology Limited | -13.81 Million AUD | -206.27% |
| Biome Australia Limited | -1.67 Million AUD | -2434.09% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | -205.157% |
| BTC Health Limited | 1.05 Million AUD | 4110.703% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | -237.789% |
| CSL Limited | 2.64 Billion AUD | 101.602% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 218.768% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 707.718% |
| Hexima Limited | -933.87 Thousand AUD | -4432.14% |
| Immutep Limited | -39.89 Million AUD | -6.086% |
| Memphasys Limited | -4.44 Million AUD | -852.819% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 126.944% |
| Noxopharm Limited | -3.57 Million AUD | -1082.869% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -413.768% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 11.731% |
| Starpharma Holdings Limited | -8.16 Million AUD | -418.364% |
| Tissue Repair Ltd | -4.13 Million AUD | -922.798% |
| Biotron Limited | -3.43 Million AUD | -1131.606% |
| Alterity Therapeutics Limited | -19.12 Million AUD | -121.322% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -2816.428% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -1656.799% |
| Zelira Therapeutics Limited | -36.56 Million AUD | -15.739% |
| Patrys Limited | -3.53 Million AUD | -1095.892% |
| Orthocell Limited | -7.18 Million AUD | -489.398% |
| Imugene Limited | -149.68 Million AUD | 71.723% |
| PYC Therapeutics Limited | -37.72 Million AUD | -12.191% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -563.786% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -334.332% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -383.927% |
| Nanollose Limited | -1.15 Million AUD | -3559.532% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -2477.914% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 13154.634% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -839.822% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -1377.644% |
| Nyrada Inc. | -1.38 Million AUD | -2953.21% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 912.213% |
| Dimerix Limited | -17.07 Million AUD | -147.872% |
| PharmAust Limited | -9.03 Million AUD | -368.587% |
| AnteoTech Limited | -8.88 Million AUD | -376.599% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 27.84% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | -139.639% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -1131.593% |
| Actinogen Medical Limited | -13.04 Million AUD | -224.467% |
| Immuron Limited | -6.93 Million AUD | -510.13% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -672.416% |